CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...